Stay updated on Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial
Sign up to get notified when there's something new on the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page.

Latest updates to the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe study record history now shows a new revision entry, v3.6.6, superseding v3.6.5. It represents an update to the record metadata rather than substantive changes to the trial details.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedA new site revision entry, v3.6.5, has been added to the record history, while the previous revision v3.6.4 was removed. This reflects an update to the page's underlying release notes and software version.SummaryDifference0.1%

- Check51 days agoChange DetectedA new revision entry (v3.6.4) was added to the study record history, replacing the previous revision (v3.6.3). This indicates an update to the study record metadata on the page.SummaryDifference0.1%

- Check72 days agoChange DetectedThe history now records Revision: v3.6.3 as the latest entry, replacing the previous Revision: v3.6.2. This reflects a small update to the page's revision tracking rather than any changes to study data or content.SummaryDifference0.1%

- Check80 days agoChange DetectedNew revision entry v3.6.2 has been added to the study's record history, and the prior v3.6.0 entry was removed. This reflects an update to the versioning history displayed on the page.SummaryDifference0.1%

- Check94 days agoChange DetectedA new 'Check who can join' option and a 'Find Contact Information' link were added to the study record history to support recruitment and access to contact details. The changes also include adding the v3.6.0 revision and removing the previous v3.5.5 entry.SummaryDifference0.6%

Stay in the know with updates to Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page.